2007
DOI: 10.1016/j.ejso.2007.03.022
|View full text |Cite
|
Sign up to set email alerts
|

Local recurrence of stage 1 and 2 breast cancer after skin-sparing mastectomy and immediate breast reconstruction in a 15-year series

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1

Citation Types

0
26
0
1

Year Published

2007
2007
2017
2017

Publication Types

Select...
9
1

Relationship

0
10

Authors

Journals

citations
Cited by 46 publications
(27 citation statements)
references
References 18 publications
0
26
0
1
Order By: Relevance
“…In recent years, skin-sparing mastectomy (SSM) in combination with IBR has gained in acceptance and popularity for early invasive or in situ disease (DCIS) in terms of both oncological safety and acceptable rates of postoperative complications [7][8][9][10][11][12][13][14][15]. More recent reports have also documented the effectiveness of SSM plus IBR for locally advanced disease [16][17][18][19][20][21][22][23][24]. These studies showed complication rates comparable to those of a similar group of patients who did not undergo IBR.…”
Section: Introductionmentioning
confidence: 59%
“…In recent years, skin-sparing mastectomy (SSM) in combination with IBR has gained in acceptance and popularity for early invasive or in situ disease (DCIS) in terms of both oncological safety and acceptable rates of postoperative complications [7][8][9][10][11][12][13][14][15]. More recent reports have also documented the effectiveness of SSM plus IBR for locally advanced disease [16][17][18][19][20][21][22][23][24]. These studies showed complication rates comparable to those of a similar group of patients who did not undergo IBR.…”
Section: Introductionmentioning
confidence: 59%
“…After an average follow-up of 51 months, the same authors reported only 4 LRs within the native breast skin of 146 women with stage 0-2 IBC treated with SSM and IBR. Following surgical and oncological treatment none of these patients developed new recurrences after a mean of 35 months, suggesting that not all local relapses are associated with disseminated disease [62]. The largest series [63] observed 539 patients over a period of 65 months, 30.6% of cases had noninvasive disease and the overall LR rate was 5.5%.…”
Section: Oncological Considerationsmentioning
confidence: 97%
“…In contrast to mastectomy, IBR has been shown to provide better cosmetic outcome and superior quality of life, without compromising oncological safety (2)(3)(4)(5)(6)(7)(9)(10)(11)(12)(13)(40)(41)(42)(43)(44).…”
Section: Discussionmentioning
confidence: 99%